From Pilot to Proof: Why Enterprise Digital Health Evidence Must Enter the Published Record

Abstract

Objective: Enterprise digital health has shifted from pilots to operational infrastructure across life sciences, health systems, medical technology, and digital health companies. Yet much of the most actionable evidence remains confined to internal reports, dashboards, pilot readouts, and operational memos. This perspective argues that publishing enterprise evidence is a practical requirement for trust, reproducibility, and responsible scale.

Methodology: Narrative synthesis grounded in recurring enterprise implementation patterns and pragmatic evaluation approaches used in real deployments. AI assistance used for drafting and editing is disclosed, consistent with journal policy.

Setting: Enterprise environments where telehealth, remote monitoring, digital endpoints, AI-enabled workflows, clinical decision support, and decentralized or hybrid trial methods are designed, deployed, and assessed.

Results: Enterprises routinely generate publishable evidence through implementation evaluations, pragmatic outcomes studies, operating model and protocol descriptions, governance case studies (including AI oversight), interoperability lessons learned, and equity analyses. Common barriers include time, uncertainty about what qualifies, imperfect real-world data, and legal constraints. These are often addressable through scoped manuscript types, de-identification or aggregation, and explicit limitations. Negative or mixed results can be especially valuable because they reveal failure modes and reduce repeated mistakes.

Conclusions: Publishing enterprise evidence accelerates learning, supports safer scale, and strengthens the credibility of telehealth and digital medicine. THMT is positioned as a pragmatic home for applied, real-world digital health work. Enterprises should treat publication as part of responsible digital health implementation and care transformation.